This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jane L. Kardashian, MD; Herschel S. Zackheim, MD; Barbara M. Egbert, MD

Arch Dermatol. 1985;121(9):1175-1180.

Abstract
• A 47-year-old black man had typical papulonodular lesions of lymphomatoid papulosis (LyP) with concurrent plaque-stage mycosis fungoides (MF). Both diagnoses were confirmed histologically. This supports the concept that LyP is part of the spectrum of cutaneous T-cell lymphoproliferative disorders. The patient also had a large nodule and a deeply infiltrated plaque, each of which exhibited a deep granulomatous reaction. These were interpreted as representing granulomatous MF. Clinically, there was an evolution from a predominance of LyP lesions to a predominance of MF plaques. Topical carmustine therapy resulted in a substantial decrease in the number and size of both LyP and MF lesions. Both lesion types involuted with hypopigmentation.

(Arch Dermatol 1985;121:1175-1180)

Author Affiliations
From the Departments of Dermatology (Drs Kardashian and Zackheim) and Pathology (Dr Egbert), University of California School of Medicine, San Francisco.

Footnotes
Accepted for publication Jan 16, 1985.

Reprint requests to 133 Arch St, Redwood City, CA 94062 (Dr Zackheim).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lymphomatoid Papulosis Followed by Hodgkin's Lymphoma: Differential Response to Therapy
Zackheim et al.
Arch Dermatol 1993;129:86-91.
ABSTRACT  

Topical Carmustine Therapy for Lymphomatoid Papulosis
Zackheim et al.
Arch Dermatol 1985;121:1410-1414.
ABSTRACT